Dr. Roy's Take On Merkel Cell Carcinoma

Dr. David Roy • May 30, 2017
Merkel Cell Carcinoma | Pine Belt Dermatology
Most of us are familiar with the more common skin cancers – basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. One that you may not be aware of is Merkel cell carcinoma (MCC). The first report of this cancer was in 1972. Since that time, the incidence of MCC has increased significantly. Between 1986 and 2001 the incidence of MCC increased approximately 8% each year.

So what is Merkel cell carcinoma, and how does it differ from the other carcinomas? It is a very rare cancer of a specialized cell of the skin. This cell, known as a Merkel cell, is thought to play a role in sensation and how we feel light touch. Compared to other skin cells, much less is known about these cells, and they are a bit of a mystery. The reason we worry about MCC is that it is very aggressive. In comparison to other skin cancers, MCC can typically behave like a very aggressive melanoma. Around 30% of people with MCC die within 2 years. That number increases to 50% at 5 years. To make things worse, we still do not know the best course of treatment for the condition.

MCC typically appears on the skin as a small flesh colored to red/violet raised bump that is painless. It is frequently confused for a harmless lesion by patients, and for less aggressive cancers (basal cell carcinoma) by doctors. This is because it so rarely seen. Only around 1500 cases a year are diagnosed. The most common sites to develop a MCC are the face, upper arm/shoulder, lower leg/hip, trunk, and scalp and neck.

The mnemonic AEIOU is used to describe the appearance of MCC and the typical type of patient in whom it is seen. A is for asymptomatic, E is for expanding rapidly, I is for immune suppression, O is for older than 50 years, and U is for ultraviolet-exposed/fair skin. Most patients who suffer from MCC are of advancing age. Men are more likely to develop this cancer, especially those with a significant history of UV exposure. Patients who are immunosuppressed have a significantly higher risk of many types of cancer, including MCC. These include patients who have received organ transplants and who take immunosuppressive drugs to prevent rejection, certain cancer patients like patients with chronic lymphocytic leukemia (CLL), and those patients with immunodeficiency syndromes. It is very rare for a person younger than 50 to develop a MCC.
 
In 2008, an association between MCC and a specific virus known as polyomavirus was observed. It is now known that up to 80 percent of patients with MCC are infected with this virus and it is believed that this virus plays some role in MCC. It is important to note that not all cases of MCC are associated with this virus.

Once diagnosed, this cancer must be distinguished from certain types of metastatic lung cancer. Involvement of other sites must be ruled out and often tests such at CT scans are performed. Because of the rarity of the tumor, no one is sure what the best type of testing is, as there is much still left to learn about this type of cancer. Treatment of MCC involves surgical removal of all affected skin and tissue and evaluation of the surrounding lymph nodes. Radiation is frequently used after surgery to treat the involved skin and lymph nodes. On March 23, 2017 the FDA announced approval a drug called Avelumab for the treatment of metastatic MCC. This is the first drug ever approved by the FDA for MCC. Avelumab is what is known as a check-point inhibitor. It uses the patient’s own immune system to fight the cancer. By blocking certain molecular structures that typically keep the immune system in check, this medication allows the immune system to accelerate and function at a higher level, which in theory allows the patient’s own immune cells (T-cells) to kill the tumor.

The important thing to remember about MCC, and most cancers for that matter, is that early detection is the best way to prevent spread of the cancer. Recognizing new or changing spots on your skin, and having them evaluated by a physician is very important. If you are unsure about a spot, get it checked! Any spot that develops quickly, grows rapidly, or changes in any way needs to be considered for a biopsy. Remember, if it grows, it goes (most of the time).

Thank you for reading about MCC, and let us know if there are any other topics that you are interested in knowing more about.
Nail Health: What Your Nails Say About Your Skin and Body
May 1, 2026
At Pine Belt Dermatology & Skin Cancer Center, we believe your nails are more than a cosmetic feature—they give valuable insight into...
April 13, 2026
When a ‘Rash’ Might Be Something More Serious At Pine Belt Dermatology & Skin Cancer Center, we recognize that rashes are common and frequently resolve quickly with minimal treatment. However, some rashes may signify underlying conditions that require prompt medical attention. Identifying when a rash is more than a minor irritation is key to protecting your health. Comprehending Common vs. Concerning Rashes Most everyday rashes result from irritants, allergies, heat, or minor infections and typically improve within a few days with over-the-counter treatments. However, if a rash lasts longer, worsens, or appears with other symptoms, it may signal a more serious issue. Identifying the difference between a routine rash and one that requires medical evaluation helps avoid complications and ensure appropriate care. Warning Signs to Watch For Certain features may indicate a rash requires clinical assessment, including: Rapidly spreading or worsening rash Severe pain, swelling, or blistering Signs of infection such as pus, warmth, or red streaks Fever or flu-like symptoms accompanying the rash A rash that does not improve after several days of treatment Dark, purple, or bruised-looking areas on the skin For example, a rash with fever may indicate a viral or bacterial infection, whereas painful blistering can suggest conditions such as shingles. In rare cases, rashes may signal autoimmune disorders or severe allergic reactions. Rashes That May Point to Underlying Conditions Some rashes may be linked to broader health concerns, including conditions that cause inflammation in the skin and other organs: Allergic reactions that may escalate into further severe responses Infections that spread beyond the skin if untreated Medication reactions that require immediate adjustment Persistent or unusual skin changes may be early signs of skin cancer or precancerous conditions, especially if they do not heal or continue to change over time. Why Early Evaluation Matters Delaying care for a worrisome rash may allow the underlying condition to progress. Early diagnosis improves treatment outcomes and helps prevent discomfort and complications. A dermatology specialist can assess the rash’s appearance, location, and progression, and may recommend diagnostic tests if needed. This approach assures treatment addresses the underlying cause, not just the visible symptoms. When to See a Dermatology Specialist If you are unsure about your rash, it is best to err on the side of caution. Consider seeking care if: The rash is persistent, painful, or unusual in appearance Over-the-counter treatments are not effective You experience additional symptoms such as fever or fatigue The rash interferes with your daily comfort or quality of life At Pine Belt Dermatology & Skin Cancer Center, our experienced providers supply comprehensive skin evaluations and customized treatment plans. We take time to understand your symptoms and deliver clear, effective solutions tailored to your needs. Protecting Your Skin and Your Health While many rashes are minor, some may be early warning signs of more serious health concerns. Monitoring skin changes and pursuing prompt medical advice can produce a notable effect. If you notice a rash that does not seem right, do not ignore it. Schedule a consultation with Pine Belt Dermatology & Skin Cancer Center for expert evaluation and peace of mind. Your skin is an important indicator of your overall health, and taking it seriously supports ongoing well-being.
The Link Between Stress & Skin Conditions | Pine Belt Dermatolog
By Bob Berendsen March 1, 2026
At Pine Belt Dermatology & Skin Cancer Center, we know that healthy skin is affected by more than just external care—it’s related to your overall health...
UV Light Therapy for Scalp Psoriasis | Pine Belt Dermatology
By Bob Berendsen February 5, 2026
Here’s how UV light therapy works, why it is useful for scalp psoriasis during winter, what to expect from treatment, and how to use it safely.
Dermatologist-Approved Tips for Safe and Effective Skincare | Pine Belt Dermatology
By Bob Berendsen January 1, 2026
A truly effective skincare routine should be tailored to your needs, protect your natural barrier, and target concerns with proven ingredients.
Psoriasis During the Winter Season | Pine Belt
By Bob Berendsen December 2, 2025
The cold, dry air outside combined with indoor heating can strip away your skin’s natural moisture, leaving it tight, flaky, and more vulnerable to irritation.
Winter Skin Survival Guide: How to Combat Dryness | Pine Belt Dermatology
By Bob Berendsen November 4, 2025
At Pine Belt Dermatology, we understand how winter weather affects your skin and how frustrating it can be to deal with the discomfort that comes with it.
Why Breakouts Increase in Cooler Weather | Pine Belt
By Bob Berendsen October 1, 2025
Acne is often thought of as a summer skin concern. However, many people notice that their breakouts actually worsen in the fall.
Sun Damage Doesn’t Stop in Fall: Why Year-Round SPF Is Essential | Pine Belt Dermatology
By Bob Berendsen September 1, 2025
This blog explores why SPF isn’t just a summer essential—it’s a daily requirement, no matter the season.
How to Reverse Sun Damage and Hyperpigmentation | Pine Belt
By Bob Berendsen August 1, 2025
Fortunately, with the right approach and treatments, you can begin reversing these effects and restore your skin’s health and radiance.